summary
Introduced
01/16/2026
01/16/2026
In Committee
02/25/2026
02/25/2026
Crossed Over
02/10/2026
02/10/2026
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
AN ACT Relating to coverage for HIV antiviral drugs; reenacting 2 and amending RCW 41.05.017; and adding a new section to chapter 48.43 3 RCW. 4
AI Summary
This bill requires health plans issued or renewed on or after January 1, 2027, to cover all HIV antiviral drugs approved by the U.S. Food and Drug Administration (FDA) without requiring prior authorization, step therapy, or other utilization management protocols, which are procedures insurers use to control costs and ensure appropriate drug use. However, if the FDA has approved multiple versions of a drug that are therapeutically equivalent, meaning they work the same way, the health plan is not obligated to cover all of them without these protocols, as long as at least one equivalent version is covered without them. The bill also amends existing law to ensure that health plans, including those not typically regulated under Title 48 RCW (which governs insurance in Washington state), are subject to these new coverage requirements for HIV antiviral drugs.
Committee Categories
Health and Social Services
Sponsors (13)
Marko Liias (D)*,
Jessica Bateman (D),
Annette Cleveland (D),
Manka Dhingra (D),
Paul Harris (R),
Bob Hasegawa (D),
T'wina Nobles (D),
Jamie Pedersen (D),
Rebecca Saldaña (D),
Derek Stanford (D),
Yasmin Trudeau (D),
Javier Valdez (D),
Claire Wilson (D),
Last Action
Third reading, passed; yeas, 93; nays, 1; absent, 0; excused, 4. (on 03/03/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...